GlassScriptPhysician profile
Stephanie Quach
NPI 1316488976
$1,282.06
in general payments reported to CMS, 2019-2025
17 companies · $904 in 2025
The $904 reported for 2025 was more than what 83% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.14 · 2022: $22.48 · 2023: $197 · 2024: $143 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.45 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $212.93 | 2024-2025 | Conmed Biliary |
| Boston Scientific Corporation | $203.79 | 2023-2025 | Bulkamid, Exalt Model D |
| Janssen Biotech, INC. | $138.71 | 2025 | Tremfya |
| Abbvie INC. | $124.78 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $95.56 | 2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $76.85 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $67.71 | 2022-2025 | Eohilia, Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.20 | 2025 | Xifaxan, Relistor |
| Genzyme Corporation | $48.18 | 2025 | |
| Braintree Laboratories, INC. | $43.98 | 2021-2025 | Sutab, Suflave |
| Medtronic, INC. | $39.63 | 2024 | Barrx |
| Merck Sharp & Dohme LLC | $32.90 | 2025 | |
| Qol Medical, LLC | $31.56 | 2025 | Sucraid |
| Enterra Medical, INC. | $29.70 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $29.13 | 2025 | Iqirvo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $27.60 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $18.85 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Quach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.